Recent Advance in the Research of Flavonoids as Anticancer Agents
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
7
Page:
663-678
Author(s):
Yanling Li, Hao Fang, Wenfang Xu, Yanling Li, Hao Fang and Wenfang Xu
Current Evidence from Phase III Clinical Trials of Selenium Supplementation in Critically Ill Patients: Why Should We Bother?
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
7
Page:
693-699
Author(s):
S. Peter Stawicki, Melanie Lyons, Marianne Aloupis, Babak Sarani, S. Peter Stawicki, Melanie Lyons, Marianne Aloupis and Babak Sarani
Tumor Suppression by DNA Base Excision Repair
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
7
Page:
727-743
Author(s):
G. Frosina and G. Frosina
The Application of Single Nucleotide Polymorphism Microarrays in Cancer Research
Journal:
Current Genomics
Volume:
8
Page:
219-228
Author(s):
Xueying Mao, Bryan D. Young and Yong-Jie Lu
The Role of Stress Proteins in Prostate Cancer
Journal:
Current Genomics
Volume:
8
Page:
252-261
Author(s):
Alan So, Boris Hadaschik, Richard Sowery and Martin Gleave
Cancer Pharmacogenomics: Germline DNA, Tumor DNA, or Both?
Journal:
Current Pharmacogenomics
Volume:
5
Page:
87-101
Author(s):
E. Cerri, A. Falcone and F. Innocenti
Secondary Metabolites from Cordyceps Species and Their Antitumor Activity Studies
Journal:
Recent Patents on Biotechnology
Volume:
1
Page:
123-137
Author(s):
Jian-Hui Xiao and Jian-Jiang Zhong
Patents on Immunotoxins and Chimeric Toxins for the Treatment of Cancer
Journal:
Recent Patents on Drug Delivery & Formulation
Volume:
1
Page:
105-115
Author(s):
Christopher Bachran, Mark Sutherland, Diana Bachran and Hendrik Fuchs
Dynamic Contrast-Enhanced MRI in Oncology Drug Development
Journal:
Current Clinical Pharmacology
Volume:
2
Page:
111-122
Author(s):
Hai-Ling Margaret Cheng
MUC1 is a Promising Therapeutic Target for Prostate Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
259-271
Author(s):
Y. Li and P. J. Cozzi